Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,747,845
-
Total 13F shares
-
1,156,685
-
Share change
-
-18,728
-
Total reported value
-
$4,591,000
-
Price per share
-
$3.97
-
Number of holders
-
16
-
Value change
-
-$184,271
-
Number of buys
-
4
-
Number of sells
-
8
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q2 2021
As of 30 Jun 2021,
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,156,685 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, EDGEWOOD MANAGEMENT LLC, SYNOVUS FINANCIAL CORP, SeaCrest Wealth Management, LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.